Fina Biotech (formerly, Indas Biotech), founded in 2002, is a spin-off of LABORATORIOS INDAS. Our mission is to select, finance, conduct, develop and market biotechnology projects.

We believe in the great potential of the Spanish researchers. Proof of this confidence can be found in the 28 projects that FINA BIOTECH has undertaken since 2002, with an investment of almost €12 million, in partnership with public and private institutions, laboratories and universities, all of them Spanish.

The main areas in which we have invested to date are:

  • Cancer diagnosis/prognosis: bladder, prostate, colon, breast and lung cancer.
  • Autologous adult stem cell therapy: cardiac regeneration after myocardial infarction, sphincter regeneration in urinary incontinence, bone regeneration (arthrodesis) and brain tissue regeneration after hemorrhagic stroke.
  • Cardiovascular diseases: DVT, risk of reestenosis markers.
  • Fertility: HALOSPERM®.
  • Liver damage markers.
  • Anti-glioblastoma therapy.

Evolution of
the corporate identity






© 2013 Fina Biotech. Madrid. Tel +34 917 991 564 info@finabiotech.es

Enlaces a redes sociales